logo
Plus   Neg
Share
Email

Eli Lilly Shares To Be Delisted From Euronext Paris On Oct. 31 - Quick Facts

Eli Lilly And Co. (LLY) said the Board of Euronext Paris has approved the company's request to delist shares. The company's decision was due to the very low trading volume, costs and administrative requirements related to its secondary listing. The shares will remain listed on the NYSE.

Eli Lilly will provide a voluntary sales facility procedure on the NYSE to its Euronext shareholders. BNP Paribas Securities Services, acting as centralizing agent, will calculate the average sale price of the Lilly shares. Lilly will pay the fees for the centralization and the brokerage fee under the sales procedure. Shareholders who do not wish to sell their Lilly shares will be able to trade only on the NYSE following the delisting.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT